Outcomes and Characteristics of Patients with Intraprocedural Cardiopulmonary Resuscitation during TAVR

Abstract

Background Transcatheter aortic valve replacement (TAVR) has become an established alternative to surgical aortic valve replacement (AVR) for higher risk patients. Periprocedural TAVR complications decreased with a growing expertise of implanters. Yet, TAVR can be accompanied by life-threatening adverse events such as intraprocedural cardiopulmonary resuscitation (CPR). This study retrospectively analyzed predictors and outcomes in a cohort of patients from a high-volume center undergoing periprocedural CPR during TAVR.

Methods A total of 729 patients undergoing TAVR, including 59 with intraprocedural CPR, were analyzed with respect to peri- and postprocedural outcomes.

Results Patients undergoing CPR showed a significantly lower left ventricular ejection fraction (LVEF) and lower baseline transvalvular mean and peak pressure gradients. The systolic blood pressure measured directly preoperatively was significantly lower in the CPR cohort. CPR patients were in a higher need for intraprocedural defibrillation, heart–lung circulatory support, and conversion to open heart surgery. Further, they showed a higher incidence of atrioventricular block grade III , valve malpositioning, and pericardial tamponade. The in-hospital mortality was significantly higher after intraprocedural CPR, accompanied by a higher incidence of disabling stroke, new pacemaker implantation, more red blood cell transfusion, and longer stay in intensive care unit.

Conclusion Impaired preoperative LVEF and instable hemodynamics before valve deployment are independent risk factors for CPR and are associated with compromised outcomes. Heart rhythm disturbances, malpositioning of the prosthesis, and pericardial tamponade are main causes of the high mortality of 17% reported in the CPR group. Nevertheless, mechanical circulatory support and conversion to open heart surgery reduce mortality rates of CPR patients.

Keywords

TAVR - cardiopulmonary resuscitation - CPR - low ejection fraction

^* Gerfer S. and Kuhn E.W. share the first authorship and Eghbalzadeh K. and Wahlers T.C.W. share the last authorship equally.

Publikationsverlauf

Eingereicht: 16. März 2022

Angenommen: 16. Mai 2022

Artikel online veröffentlicht:
19. Juli 2022

• References

• 1 Mack MJ, Leon MB, Smith CR. et al; PARTNER 1 trial investigators. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet 2015; 385 (9986): 2477-2484
• 2 Reardon MJ, Van Mieghem NM, Popma JJ. et al; SURTAVI Investigators. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. N Engl J Med 2017; 376 (14) 1321-1331
• 3 Cormican D, Jayaraman A, Villablanca P, Ramakrishna H. TAVR procedural volumes and patient outcomes: analysis of recent data. J Cardiothorac Vasc Anesth 2020; 34 (02) 545-550
• 4 Popma JJ, Deeb GM, Yakubov SJ. et al; Evolut Low Risk Trial Investigators. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med 2019; 380 (18) 1706-1715
• 5 Mack MJ, Leon MB, Thourani VH. et al; PARTNER 3 Investigators. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med 2019; 380 (18) 1695-1705
• 6 Pineda AM, Harrison JK, Kleiman NS. et al. Incidence and outcomes of surgical bailout during TAVR: insights from the STS/ACC TVT registry. JACC Cardiovasc Interv 2019; 12 (18) 1751-1764
• 7 Huang H, Kovach CP, Bell S. et al. Outcomes of emergency transcatheter aortic valve replacement. J Interv Cardiol 2019; 2019: 7598581
• 8 Wilde N, Sugiura A, Sedaghat A. et al. Risk of mortality following transcatheter aortic valve replacement for low-flow low-gradient aortic stenosis. Clin Res Cardiol 2021; 110 (03) 391-398
• 9 Kiramijyan S, Koifman E, Magalhaes MA. et al. Intraprocedural invasive hemodynamic parameters as predictors of short- and long-term outcomes in patients undergoing transcatheter aortic valve replacement. Cardiovasc Revasc Med 2018; 19 (3 Pt A): 257-262
• 10 Liang Y, Dhoble A, Pakanati A. et al. Catastrophic cardiac events during transcatheter aortic valve replacement. Can J Cardiol 2021; 37 (10) 1522-1529
• 11 Huang HD, Mansour M. Pacemaker implantation after transcatheter aortic valve replacement: a necessary evil perhaps but are we making progress?. J Am Heart Assoc 2020; 9 (09) e016700